|
|
||||||||
Eur J Cardiothorac Surg 2003;24:879-885
© 2003 Elsevier Science NL
Department of Cardiology and Cardio-thoracic Surgery, Policlinico Universitario, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
Received 3 July 2003; received in revised form 20 August 2003; accepted 26 August 2003.
* Corresponding author. Tel.: +39-049-8212310; fax: +39-049-8761764
e-mail: giuseppe.tarantini.1{at}unipd.it
| Abstract |
|---|
|
|
|---|
90 ml/m2 was the best cut-off value (sensitivity and specificity 78%) to fit with a better survival (93% vs. 63%, P<0.01) and with LVEF recovery after aortic valve replacement (EF improved by 15±10% vs. 8±5%, P<0.001). Conclusions: Despite LV dysfunction, aortic valve replacement appears to change drastically the natural history of severe aortic stenosis. Preoperative LV levels predict different postoperative survival rate and LVEF recovery.
Key Words: Aortic stenosis Surgery Survival Ventricular function
| 1. Introduction |
|---|
|
|
|---|
Predictors of postoperative survival and LV function after aortic valve replacement for severe aortic stenosis with LV dysfunction have not been clearly identified. Therefore, we hypothesized that the rate of postoperative cardiac death and LV function recovery could be related to preoperative indexes of LV dysfunction representative of prevalent myocardial damage rather than afterload mismatch. The aim of this study was to examine the outcome of these patients and to further assess potential preoperative predictors of postoperative cardiac death and LV function recovery.
| 2. Material and methods |
|---|
|
|
|---|
2.2. Echocardiographic methods
All patients underwent comprehensive 2D and Doppler transthoracic echocardiographic assessment, 64 (75%) patients in our institution and 21 (25%) in other hospitals, <30 days before admission for cardiac catheterization. LVEF were determined by volumetric methods [8]. Aortic valve hemodynamic data were assessed using standard methods, and the aortic valve area was calculated with the continuity equation [9]. Mitral and aortic regurgitation was semiquantitated from 0 (none) to 4+ (severe) by analysis of color flow Doppler [10,11]. All postoperative studies were performed with echocardiography. Median time from surgery to postoperative echocardiography was 14.1 months.
2.3. Angiographic methods
In our center, preoperative hemodynamic assessment of adult aortic stenosis included right and left cardiac catheterization and coronary angiography in all patients. With fluid filled catheter, LV and systemic arterial pressures were recorded simultaneously. Cardiac output and index were measured at the time of cardiac catheterization, and aortic valve area was calculated from the Gorlin equation [12]. Peak-to-peak transvalvular gradient was used. Cardiac output was determined by the Fick method. All patients underwent aortography at 60° left anterior oblique view to evaluate aortic insufficiency. From left ventriculography, end-diastolic volume index (EDVI), end-systolic volume index (ESVI) and EF were calculated by the area-length method with the correction for 30° right anterior oblique projection [13]. Mitral and aortic regurgitation were semiquantitated from 0 (none) to 4+ (severe) [14]. Selective coronary angiography was performed in different angled projections. Coronary artery disease was defined as
70% lumen diameter narrowing of the left main or major epicardial vessels. Multivessel coronary artery disease was defined as either left main or two or three major epicardial vessel disease. When both preoperative echocardiographic and ventriculographic data of LVESVI, LVEDVI and LVEF were available, the angiographic value were used for statistical analysis. The mean difference in LVEF between modalities was 1% (P<0.35).
2.4. Surgical procedures
Fifty-two patients (61%) underwent aortic valve replacement. All surgical records were reviewed in order to determine the type and size of aortic valve prosthesis and to show whether coronary artery bypass graft surgery was performed concomitantly with aortic valve replacement. The surgical procedures performed, along with cross-clamp and cardiopulmonary bypass times, were included in database for the analysis. In-hospital death was defined as death before hospital discharge. After discharge, death were classified as either cardiac or non-cardiac. Deaths for which a non-cardiac cause was no clearly documented were considered to be cardiac related.
2.5. Statistical analysis
Data are expressed as mean value±standard deviation for continuous variables, as numbers with percentage for categorical variables. The paired and unpaired Student test was performed to determine intragroup and intergroup differences between mean values for continuous variable, as appropriate. Categorical variables were analyzed by chi-square test or Fisher's exact test as appropriate. Multivariate logistic models were fit to identify preoperative variables related to postoperative cardiac death. Overall survival and death not due to heart disease were estimated by the use of the KaplanMeier method. Receiver operating characteristic (ROC) curve analysis was performed to establish the diagnostic accuracy and the value of preoperative end systolic volume index as predictor of cardiac death. Comparison of intergroup changes between preoperative and postoperative echocardiographic values used the non-parametric MannWhitney U-test. A P value <0.05 was considered significant. Data were analyzed with SPSS for Windows, release 10 (SPSS Inc., Chicago, IL).
| 3. Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
90 ml/m2 group compared with 8±5% in the LVESVI>90 ml/m2 group (P<0.001) (Table 5).
|
| 4. Discussion |
|---|
|
|
|---|
4.1. Non-operated patients
In our study all non-operated patients died within 40 months. This is in agreement with the common knowledge about the fate of severe aortic stenosis: a rapid death after the onset of heart failure. Although their profile is not completely super imposable to that of operated patients, they still have a severe aortic stenosis (aortic valve area 0.7±0.3 cm2), a virtually identical LVEF (28%) and a smaller, but still significant, transaortic gradient (45 mmHg). Since the majority of non-operated patients were hypertensive, an elevated arterial pressure at the moment of cardiac catheterization could well have decreased the gradient contributing to underestimate stenosis severity. In summary, this group seems to be very similar in many aspects to that of operated patients. Thus, we may consider the latter as control group.
4.2. Survival after aortic valve replacement and predictors of cardiac death
Operated patients have a narrower valve and less comorbidities respect to non-operated patients. They showed a low perioperative mortality of 8% and an improved survival at long term follow-up. These findings are similar to those in previous series; however, there is only the report of Connolly [6] on surgical or late outcome in a large group of patients with aortic stenosis and substantial LV dysfunction. Many of the reported series have included patients undergoing aortic valve replacement for both aortic regurgitation and aortic stenosis [15,16]. Furthermore, the other reported surgical series are largely older series, and surgical techniques, particularly regarding myocardial preservation, have advanced since that time. In the report of Connolly early mortality was 9% and related, by multivariate analysis, to the presence of coronary artery disease, while late mortality was related to the presence of coronary artery disease in addition to preoperative cardiac output. Since all patients had reduced LV function, further LVEF analysis was not related to survival. As we know from physiology, not all LVEF are created equally, so, in our study, we included LVEF, LVESVI, LVEDVI as potential covariates of outcome hypothesizing that postoperative survival and recovery of LV function might be related to preoperative indexes of LV dysfunction representative of prevalent myocardial damage rather than afterload mismatch. By multivariate analysis, we failed to find independent predictors of in-hospital mortality while LVESVI resulted as independent covariate of total cardiac mortality. In our series, coronary artery disease was less frequent than that reported by Connolly and was treated successfully in all cases. LVESVI is a well established prognostic indicator in patients with mitral or aortic regurgitation, even if LVEF is normal. Such patients appear to represent a high risk group with an increased incidence of sudden death if not operated on, and with a considerable postoperative mortality once symptoms and/or LV systolic dysfunction developed [17]. Although LVESVI does not intervene as criteria for valve replacement in severe aortic stenosis, it remains a significant prognostic indicator, in the subgroup of patients with severe aortic stenosis and LV dysfunction.
4.3. LV function after aortic valve replacement
In our study, aortic valve replacement was associated with improved LVEF, as shown by others [3,18]. We also studied the relation between preoperative LVESVI and the extent and type of LV function recovery. After aortic valve replacement, LVEF increased markedly, due to a decrease in LVESVI, while LVEDVI remained unchanged. Although the LV volumes have been evaluated and analyzed largely by cineangiography before surgery, and by echocardiogram thereafter, we think that our study findings remain essentially true. LVEF is a non-dimensional parameter, therefore its evaluation is largely independent from the instrumentation used for measuring it. Previous studies have documented acceptable correlations between angiography and echocardiography and have confirmed reproducibility [19,20]. Indeed the mean difference in preoperative LVEF between modalities was 1% (P<0.37). Thus, we are almost sure that EF is actually increased after aortic valve replacement. Problems can arise as far as evaluation of absolute volumes is concerned, because volumes are not dimensionless. However, whatever the means of measurement, changes in LVESVI are much more marked than changes in EDVI, and, since pumping ability is certainly increased, as explained before, we can reasonably hypothesize that increased EF is most probably due to a decrease in LVESVI, without affecting preload significantly. Depending on angiographic LVESVI, we found differences between pre- and postoperative LVESVI and also between pre- and postoperative LVEF. This difference lessens in the group of patients with smaller to those with larger LVESVI, determining a gradient of LV function recovery as expressed by LVEF changes. Although LVEDVI did not change significantly, all patients showed a reduction of LVESVI during follow-up, but changes were still prevalent in the group with smaller preoperative LVESVI. Since at end systole volume is essentially independent of preload and is apparently dependent only upon contractile state and loading condition, we may reasonably consider this behavior to be teleologically explained by a prevalent afterload mismatch as cause of LV dysfunction in the group of patients with mild LV dilatation; in contrast patients with large preoperative LV volume showed less benefit in terms of LVEF and LVESVI changes, which may be reasonably explained by prevalent myocardial damage instead of afterload mismatch. The case of valvular cardiomyopathy may be considered in the latter group [7] with a long term survival trend similar to that reported recently among community subjects in the Framingham Heart Study after the onset of heart failure [21].
In conclusion, we maintain that severe aortic stenosis rarely has clinical contraindications to surgery for cardiac reasons and, even in severely ill patients, the surgical risk is surprisingly low. In-hospital survival does not seem to depend on LV function, although late survival does. Postoperative improvement of LV function is related to preoperative LVESVI, but LVESVI improvement is less in patients with smaller to those with larger preoperative LVESVI determining a gradient of LV function recovery as expressed by LVEF changes. Evaluation of LV function before surgery should include LVESVI measurement, which gives insight both on late survival and LV function recovery after aortic valve replacement in such patients.
4.4. Limitations
This is a retrospective case-series study of consecutive patients admitted to a single center and monitored for nearly 20 years. Our patients represent a relatively small sample size because severe aortic stenosis and left ventricular dysfunction is a rare association, in fact only a few larger series of such patients can be found in literature.
The two groups of patients (i.e. operated and not operated on) are not statistically matched because of the small sample size; however, most of the major prognostic variables are comparable between the two groups (i.e. age, gender, LVEF, CAD, etc.). In spite that the number of patients is small, we were able to demonstrate significant differences in mortality rate and left ventricular function recovery.
At echocardiographic follow-up we lost three out of 52 patients; this should be considered in the interpretation of results, since performing echocardiography may have been an indicator for better outcome.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. L. Hannan, Z. Samadashvili, S. J. Lahey, C. R. Smith, A. T. Culliford, R. S.D. Higgins, J. P. Gold, and R. H. Jones Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality. Ann. Thorac. Surg., June 1, 2009; 87(6): 1741 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bovill, S. Westaby, A. Crisp, S. Jacobs, and T. Shaw Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 853 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Bermejo and R Yotti Low-gradient aortic valve stenosis: value and limitations of dobutamine stress testing Heart, March 1, 2007; 93(3): 298 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, D. Nercolini, S. Tapiero, P.-Y. Litzler, J.-P. Bessou, and V. Babaliaros Treatment of Calcific Aortic Stenosis With the Percutaneous Heart Valve: Mid-Term Follow-Up From the Initial Feasibility Studies: The French Experience J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1214 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chukwuemeka, V. Rao, S. Armstrong, J. Ivanov, and T. David Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 133 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Baumgartner What influences the outcome of valve replacement in critical aortic stenosis? Heart, October 1, 2005; 91(10): 1254 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Fuster, J. A. Montero Argudo, O. G. Albarova, F. Hornero Sos, S. Canovas Lopez, M. Bueno Codoner, J. A. Buendia Minano, and I. Rodriguez Albarran Left ventricular mass index as a prognostic factor in patients with severe aortic stenosis and ventricular dysfunction Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 260 - 266. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |